Daily Stock Analysis, ACRS, Aclaris Therapeutics Inc, priceseries

Aclaris Therapeutics Inc. Daily Stock Analysis
Stock Information
Open
2.09
Close
1.99
High
2.10
Low
1.98
Previous Close
2.10
Daily Price Gain
-0.11
YTD High
8.19
YTD High Date
Jan 8, 2019
YTD Low
1.93
YTD Low Date
Jun 28, 2019
YTD Price Change
-5.67
YTD Gain
-74.02%
52 Week High
20.75
52 Week High Date
Jul 23, 2018
52 Week Low
1.93
52 Week Low Date
Jun 28, 2019
52 Week Price Change
-18.49
52 Week Gain
-90.28%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
May 10. 2018
18.21
May 21. 2018
19.17
7 Trading Days
5.27%
Link
LONG
Apr 22. 2019
5.88
Apr 30. 2019
6.40
6 Trading Days
8.88%
Link
Company Information
Stock Symbol
ACRS
Exchange
NasdaqGS
Company URL
http://www.aclaristx.com
Company Phone
484-321-5554
CEO
Neal S. Walker
Headquarters
Pennsylvania
Business Address
SUITE 400, 101 LINDENWOOD DRIVE, MALVERN, PA 19355
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001557746
About

Aclaris Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company, which engages in identifying, developing and commercializing novel drugs to address unmet needs in dermatology. It also pursues the development of topical agents for the treatment and prevention of a number of medical and cosmetic indications. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala and Stuart D. Shanler in July 2012 and is headquartered in Malvern, PA.

Description

Developing a proprietary hydrogen peroxide treatment for common skin lesions.